Outlook Therapeutics, Inc. — All Filings
777 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
PRE 14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001104659-26-034601 | Mar 25, 2026 | Mar 23, 2026 |
| 424B5 | 424B5 | 0001104659-26-033981 | Mar 25, 2026 | — |
| 424B5 | 424B5 | 0001104659-26-033403 | Mar 23, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-028103 | Mar 16, 2026 | Mar 13, 2026 |
| 8-K | FORM 8-K | 0001104659-26-026465 | Mar 11, 2026 | Mar 6, 2026 |
| 8-K | FORM 8-K | 0001104659-26-025893 | Mar 10, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-024189 | Mar 5, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-017118 | Feb 18, 2026 | — |
| 10-Q | 10-Q | 0001104659-26-016554 | Feb 17, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001104659-26-015887 | Feb 17, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-013470 | Feb 11, 2026 | — |
| SCHEDULE 13G/A | — | 0001178913-26-000311 | Feb 5, 2026 | — |
| ARS | ARS | 0001140361-26-002408 | Jan 26, 2026 | Sep 30, 2025 |
| DEFA14A | DEFA14A | 0001140361-26-002407 | Jan 26, 2026 | — |
| DEF 14A | DEF 14A | 0001140361-26-002406 | Jan 26, 2026 | Mar 10, 2026 |
| 8-K | FORM 8-K | 0001104659-26-000066 | Jan 2, 2026 | Dec 31, 2025 |
| 10-K | 10-K | 0001104659-25-123264 | Dec 19, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-122786 | Dec 19, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-111316 | Nov 13, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-105633 | Nov 3, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004475 | Oct 21, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000010 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000009 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000008 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000007 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000006 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000005 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000004 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001649989-25-000003 | Oct 3, 2025 | Oct 1, 2025 |
| 8-K | FORM 8-K | 0001104659-25-094558 | Sep 29, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-087886 | Sep 5, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-086428 | Sep 2, 2025 | Aug 28, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-003535 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-011588 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-078622 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-012269 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003290 | Jul 31, 2025 | — |
| 4 | — | 0001415889-25-019586 | Jul 9, 2025 | Jul 1, 2025 |
| 3 | — | 0001415889-25-019585 | Jul 9, 2025 | Jul 1, 2025 |
| 8-K | FORM 8-K | 0001104659-25-064755 | Jul 1, 2025 | Jun 28, 2025 |
| 8-K | FORM 8-K | 0001104659-25-055521 | Jun 2, 2025 | — |
| SCHEDULE 13D/A | — | 0000947871-25-000572 | May 28, 2025 | — |
| 4 | — | 0000947871-25-000571 | May 28, 2025 | May 27, 2025 |
| 424B5 | 424B5 | 0001104659-25-052469 | May 23, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-052452 | May 23, 2025 | May 22, 2025 |
| 424B5 | 424B5 | 0001104659-25-052010 | May 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002404 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-007878 | May 15, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-049411 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-007873 | May 15, 2025 | Mar 31, 2025 |